Rivermark Medical, a urology-focused medical device company committed to redefining benign prostatic hyperplasia (BPH) ...

Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, ...

The Food and Drug Administration (FDA) is reviewing an ER formulation of alfuzosin hydrochloride 10 mg for once-daily administration for treatment of symptomatic BPH. The IR and twice-daily ER ...

Omada Idoko, Head of Corporate Relations at Kelina Hospital, said the hospital invests in staff training abroad and partners ...

Of the agents that interfere with testosterone's stimulatory effect on prostate size, finasteride, a 5-α-reductase inhibitor, is the only one with FDA-approved labeling for BPH treatment.

Men who suffer from benign prostatic hyperplasia can return to regular activities within a few days after the Holmium Laser Enucleation of the Prostate (HoLEP). Related Rivers, Benue, other states ...

Prostate enlargement is an abnormal enlargement of the prostate gland causing variable degrees of bladder outlet obstruction.

Dr Christopher Kelly discusses the evolution of patient outcomes with different benign prostatic hyperplasia (BPH) treatments, particularly focusing on ejaculation preservation and durability. Dr ...

From health problems to confidence issues, there are a lot of ways that erectile dysfunction can impact your life. While an ...

FDA warning on topical finasteride: The FDA issued a warning about the topical form of finasteride (generic Propecia), often ...

The present review explores the prevalence of musculoskeletal work-related injuries associated with endoscopic treatment of benign prostatic hyperplasia, ergonomic factors and potential current and ...